Prescription Drug Prices Paid Under Federal Programs: Analyses, Differences, Factors

Suzanna Elwin (Editor)

Series: Health Care in Transition
BISAC: MED049000

Clear

$140.00

Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick

eBook

Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:

Quantity:

Details

In 2011, federal spending for prescription drugs by DOD, Medicaid, and Medicare Part D totaled $71.2 billion—representing about 85 percent of all federal prescription drug expenditures—for about 114.4 million beneficiaries. Each program reimbursed retail pharmacies for outpatient prescriptions filled at these pharmacies by their beneficiaries. This book compares retail reimbursement prices paid by DOD, Medicaid, and Medicare Part D for a sample of prescription drugs and describes factors affecting these prices. It also discusses approaches to control prescription drug spending in federal programs.

(Imprint: Nova)

Preface

Chapter 1 - Prescription Drugs: Comparison of DOD, Medicaid, and Medicare Part D Retail Reimbursement Prices (pp. 1-32)
United States Government Accountability Office

Chapter 2 - Prescription Drugs: Comparison of DOD and VA Direct Purchase Prices (pp. 33-58)
United States Government Accountability Office

Chapter 3 - Prescription Drugs: Overview of Approaches to Control Prescription Drug Spending in Federal Programs (pp. 59-72)
John E. Dicken

Chapter 4 - Medicaid Prescription Drugs: CMS Should Implement Revised Federal Upper Limits and Monitor Their Relationship to Retail Pharmacy Acquisition Costs (pp. 73-108)
United States Government Accountability Office

Index

You have not viewed any product yet.